Author:
Rosenblatt Alberto,de Campos Guidi Homero Gustavo
Publisher
Springer Berlin Heidelberg
Reference113 articles.
1. Agarwal C, Hembree JR, Rorke EA, Eckert RL (1994) Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res 54: 2108–2112
2. Agliano AM, Gradilone A, Gazzaniga P, Napolitano M, Vercillo R, Albonici L, Naso G, Manzari V, Frati L, Vecchione A (1994) High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 53: 125–129
3. Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernandez P, Smith JS, Munoz N, Kornegay JR, Hernandez-Avila M, Franceschi S (2006) Human papillomavirus in men: Comparison of different genital sites. Sex Transm Infect 82: 31–33
4. Albarran YCA, de la Garza A, Cruz Quiroz BJ, Vazquez Zea E, Diaz Estrada I, Mendez Fuentez E, Lopez Contreras M, Andrade-Manzano A, Padilla S, Varela AR, Rosales R (2007) MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: A phase I/II study. BioDrugs 21: 47–59
5. Anwar K, Naiki H, Nakakuki K, Inuzuka M (1992a) High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70: 1967–1973